Laura Mazzeo
0000-0001-9226-8861
Istituto Nazionale dei Tumori
2 papers found
Refreshing results…
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis
Missing publications? Search for publications with a matching author name.